{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:32:08Z","timestamp":1795026728139,"version":"4.10.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX10202203008, 2017ZX10202203007"],"award-info":[{"award-number":["2017ZX10202203008, 2017ZX10202203007"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772171"],"award-info":[{"award-number":["81772171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pregenomic RNA (pgRNA) and hepatitis B core-related antigen (HBcrAg) play significant roles in predicting discontinuing treatment outcomes. However, their role in pregnancy has rarely been reported. We aimed to evaluate the performance of pgRNA and HBcrAg kinetics in predicting HBeAg seroconversion and HBsAg reduction postpartum in HBeAg-positive pregnant women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Pregnant HBeAg-positive patients receiving antiviral prophylaxis and ceasing treatment postpartum were included. PgRNA and HBcrAg levels were measured before treatment, at 32 weeks of gestation, and at treatment withdrawal postpartum. Other virological and biochemical parameters were regularly examined until 96 weeks postpartum.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 76 pregnant chronic hepatitis B (CHB) carriers with a median treatment duration of 18.1 weeks, HBeAg seroconversion and HBsAg reduction &amp;gt;0.3 log<jats:sub>10<\/jats:sub> IU\/mL at 96 weeks postpartum occurred in 8 (10.5%) and 13 (17.1%) patients, respectively. HBsAg correlated most strongly with pgRNA, while HBeAg correlated most strongly with HBcrAg. Multivariable regression analysis revealed that postpartum pgRNA decline and peak ALT levels were independent predictors of HBsAg reduction. The area under the curve of the regression model was 0.79 and reached as high as 0.76 through bootstrapping validation. The calibration plot showed that the nomogram had a performance similar to that of the ideal model. A decision tree was established to facilitate application of the nomogram. In addition, HBcrAg kinetics, as an independent predictor, performed poorly in predicting HBeAg seroconversion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Postpartum pgRNA decline together with peak ALT levels may identify patients with a higher probability of HBsAg reduction after treatment cessation postpartum among pregnant CHB carriers receiving antiviral prophylaxis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.1055774","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:51:35Z","timestamp":1670827895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["PgRNA kinetics predict HBsAg reduction in pregnant chronic hepatitis B carriers after treatment cessation"],"prefix":"10.3389","volume":"12","author":[{"given":"Chun-Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Chao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-qin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/MCG.0000000000000822","article-title":"Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis b","volume":"52","author":"Chang","year":"2018","journal-title":"J. Clin. Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/jvh.13613","article-title":"Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection","volume":"28","author":"Choi","year":"2021","journal-title":"J. Viral Hepatitis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1136\/gutjnl-2013-306221","article-title":"HBsAg seroclearance with NUCs: rare but important","volume":"63","author":"Cornberg","year":"2014","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Clinical practice guidelines on the management of hepatitis b virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1136\/gut.2004.062208","article-title":"Flares in chronic hepatitis b patients induced by the host or the virus? relation to treatment response during peg-interferon {alpha}-2b therapy","volume":"54","author":"Flink","year":"2005","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-2001-17861","article-title":"Immunological tolerance of the human fetus","volume":"18","author":"Gaunt","year":"2001","journal-title":"Am. J. Perinatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/gutjnl-2014-308211","article-title":"Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis b","volume":"64","author":"Giles","year":"2015","journal-title":"Gut"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis b virus infection","volume":"55","author":"Han","year":"2011","journal-title":"J. Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1186\/s12879-021-06634-2","article-title":"Characterization of T cell immunity in chronic hepatitis b virus-infected mothers with postpartum alanine transaminase flare","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3851\/IMP2777","article-title":"On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis b patients receiving nucleoside analogue therapy","volume":"20","author":"Huang","year":"2015","journal-title":"Antiviral Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/S0168-8278(20)30773-X","article-title":"Efficacy and safety results of the phase 2 JNJ-56136379 JADE study in patients with chronic hepatitis b: Interim week 24 Data.In proceedings of the digital ILC, 27\u201329 august 2020","volume":"73","author":"Janssen","year":"2020","journal-title":"J. hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/jac\/dkw019","article-title":"\u03b1-fetoprotein level-dependent early hepatitis b surface antigen decline during entecavir therapy in chronic hepatitis b with hepatitis flare","volume":"71","author":"Jeng","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11684-020-0744-2","article-title":"Eliminating mother-to-child transmission of HBV: progress and challenges in China","volume":"14","author":"Jing","year":"2020","journal-title":"Front. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.1890290102","article-title":"Postpartum subsidence of hepatitis b viral replication in HBeAg-positive carrier mothers","volume":"29","author":"Lin","year":"1989","journal-title":"J. Med. Virol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1440-1746.2006.04198.x","article-title":"Hepatitis b post-partum e antigen clearance in hepatitis b carrier mothers: Correlation with viral characteristics","volume":"21","author":"Lin","year":"2006","journal-title":"J. Gastroenterol. Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jvh.12066","article-title":"Safety of telbivudine treatment for chronic hepatitis b for the entire pregnancy","author":"Liu","year":"2013","journal-title":"J. Viral Hepatitis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","article-title":"Countdown to 2030: eliminating hepatitis b disease, China","volume":"97","author":"Liu","year":"2019","journal-title":"Bull. World Health Organ."},{"key":"B18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/jgh.13436","article-title":"Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis b virus","volume":"32","author":"Liu","year":"2017","journal-title":"J. Gastroenterol. hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/jvh.13227","article-title":"Hepatitis b virus pregenomic RNA status can reveal the long-term prognoses of chronic hepatitis b patients treated with nucleos(t)ide analogues","volume":"27","author":"Luo","year":"2020","journal-title":"J. Viral Hepatitis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/hep.31616","article-title":"HBV RNA profiles in patients with chronic hepatitis b under different disease phases and antiviral therapy","volume":"73","author":"Mak","year":"2021","journal-title":"Hepatol. (Baltimore Md)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/apt.14376","article-title":"Review article: hepatitis b core-related antigen (HBcrAg): an emerging marker for chronic hepatitis b virus infection","volume":"47","author":"Mak","year":"2018","journal-title":"Alimentary Pharmacol. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis b transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jcv.2019.01.002","article-title":"Analysis of serum hepatitis b virus RNA levels in a multiethnic cohort of pregnant chronic hepatitis b carriers","volume":"111","author":"Patel","year":"2019","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/cid\/cis859","article-title":"Close monitoring of hepatitis b surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response","volume":"56","author":"Sonneveld","year":"2013","journal-title":"Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc. America."},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2893.2007.00894.x","article-title":"Exacerbation of chronic hepatitis b infection after delivery","volume":"15","author":"ter Borg","year":"2008","journal-title":"J. Viral Hepatitis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis b virus infection in 2016: a modelling study","volume":"3","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/infdis\/jiy270","article-title":"Serum HBV RNA as a predictor of peginterferon Alfa-2a response in patients with HBeAg-positive chronic hepatitis b","volume":"218","author":"van B\u00f6mmel","year":"2018","journal-title":"J. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/jvh.13272","article-title":"Serum hepatitis b virus RNA predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis b","volume":"27","author":"van Campenhout","year":"2020","journal-title":"J. Viral Hepatitis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.14218\/JCTH.2021.00209","article-title":"Guidelines for prevention and treatment of chronic hepatitis b","volume":"9","author":"Wang","year":"2021","journal-title":"J. Clin. Trans. Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1002\/jmv.26529","article-title":"Distribution and factors associated with serum HBV pregenomic RNA levels in Chinese chronic hepatitis b patients","volume":"93","author":"Wang","year":"2021","journal-title":"J. Med. Virol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/1471-0528.16884","article-title":"The relationship between hepatitis b virus serum DNA, RNA and quantitative hepatitis b surface antigen, and the predictive value for mother-to-child transmission: an observational cohort study","volume":"129","author":"Wang","year":"2022","journal-title":"BJOG an Int. J. Obstet. Gynaecol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jhep.2016.05.029","article-title":"Serum hepatitis b virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound","volume":"65","author":"Wang","year":"2016","journal-title":"J. Hepatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/liv.13716","article-title":"ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype a HBeAg-positive chronic hepatitis b","volume":"38","author":"Wong","year":"2018","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver."},{"key":"B34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","article-title":"Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis b virus infection: a multicentre, randomized, double-blind, placebo-controlled study","volume":"16","author":"Xu","year":"2009","journal-title":"J. Viral Hepatitis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3760\/cma.j.issn.0376-2491.2018.43.008","article-title":"[Effects of tenofovir and telbivudine on HBV RNA in pregnant women with different genotypes of HBeAg-positive hepatitis b in guizhou province]","volume":"98","author":"Zhang","year":"2018","journal-title":"Zhonghua yi xue za zhi."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S878","DOI":"10.1016\/S0168-8278(20)32197-8","article-title":"Efficacy and safety of GLS4\/ritonavir combined with entecavir in HBeAg-positive patients with chronic hepatitis b: Interim results from phase 2b, multi-center study","volume":"73","author":"Zhang","year":"2020","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3760\/cma.j.issn.1007-3418.2020.01.007","article-title":"[Comments on 2019 Chinese practice guideline for the prevention and treatment of hepatitis b virus mother-to-child transmission]","volume":"28","author":"Zhou","year":"2020","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chin. J. Hepatol"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1055774\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T06:51:43Z","timestamp":1670827903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1055774\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2022.1055774"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s008","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055774.s009","asserted-by":"subject"}]},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"article-number":"1055774"}}